Shandong Weigao Medical Polymer Shares Outstanding 2012-2024 | SHWGF
Shandong Weigao Medical Polymer shares outstanding from 2012 to 2024. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
| Shandong Weigao Medical Polymer Annual Shares Outstanding (Millions of Shares) |
|
|---|---|
| 2023 | 4,519 |
| 2022 | 4,527 |
| 2021 | 4,516 |
| 2020 | 4,493 |
| 2019 | 4,483 |
| 2018 | 4,484 |
| 2017 | 4,483 |
| 2016 | 4,478 |
| 2015 | 4,478 |
| 2014 | 4,476 |
| 2013 | 4,476 |
| 2012 | 4,529 |
| 2011 | |
| Shandong Weigao Medical Polymer Quarterly Shares Outstanding (Millions of Shares) |
|
|---|---|
| 2024-06-30 | |
| 2014-06-30 | 4,476 |
| 2013-12-31 | |
| 2013-06-30 | 4,492 |
| 2012-12-31 | |
| 2012-06-30 | |
| 2011-12-31 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $3.010B | $1.872B |
| Shandong Weigao Group Medical Polymer Company Limited is engaged in the research and development, production, and sale of single-use medical devices. Single use products offered by the Company includes syringes, blood bags and blood component segregator consumables, blood sampling products, dental and anesthetic consumables, and prefilled syringes for pre-pack medication and etc. It also offers orthopedic materials and instruments like trauma products of steel plates and screws, spinal implants, and artificial joints; blood purification consumables, such as puncture needles, extracorporeal blood circuit for blood purification sets, dialyzers, PVC granules, and related consumables, as well as immunity adsorption products for the treatment of immune system diseases; and cardiovascular stents, including drug eluting stents and balloons. Shandong Weigao Group Medical Polymer Company is based in Weihai, the People's Republic of China. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $205.706B | 26.24 |
| Stryker (SYK) | United States | $139.963B | 31.54 |
| Boston Scientific (BSX) | United States | $123.141B | 35.43 |
| Medtronic (MDT) | Ireland | $115.512B | 17.19 |
| EssilorLuxottica (ESLOY) | France | $107.269B | 0.00 |
| Lonza Group Ag (LZAGY) | Switzerland | $45.495B | 0.00 |
| Haleon (HLN) | United Kingdom | $44.045B | 28.62 |
| GE HealthCare Technologies (GEHC) | United States | $39.725B | 20.60 |
| ResMed (RMD) | United States | $35.859B | 29.47 |
| Terumo (TRUMY) | Japan | $28.338B | 0.00 |
| Koninklijke Philips (PHG) | Netherlands | $24.899B | 19.06 |
| Zimmer Biomet Holdings (ZBH) | United States | $21.355B | 13.60 |
| Baxter (BAX) | United States | $18.300B | 12.41 |
| Insulet (PODD) | United States | $16.520B | 69.50 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $11.035B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $10.268B | 35.05 |
| BellRing Brands (BRBR) | United States | $8.619B | 36.44 |
| Demant (WILYY) | Denmark | $8.351B | 0.00 |
| Lantheus Holdings (LNTH) | United States | $7.497B | 18.00 |
| ICU Medical (ICUI) | United States | $4.172B | 39.82 |
| TG Therapeutics (TGTX) | United States | $4.165B | 44.10 |
| Prestige Consumer Healthcare (PBH) | United States | $3.670B | 18.28 |
| Haemonetics (HAE) | United States | $3.658B | 18.10 |
| Envista Holdings (NVST) | United States | $3.604B | 26.85 |
| Perrigo (PRGO) | Ireland | $3.559B | 11.25 |
| Neogen (NEOG) | United States | $3.129B | 36.10 |
| GN Store Nord (GNNDY) | Denmark | $2.966B | 17.86 |
| QuidelOrtho (QDEL) | United States | $2.629B | 16.57 |
| Agios Pharmaceuticals (AGIO) | United States | $2.559B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $2.178B | 36.75 |
| LeMaitre Vascular (LMAT) | United States | $2.132B | 51.85 |
| Curaleaf Holdings (CURLF) | Canada | $1.923B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $1.882B | 0.00 |
| Warby Parker (WRBY) | United States | $1.756B | 0.00 |
| AtriCure (ATRC) | United States | $1.634B | 0.00 |
| InMode (INMD) | Israel | $1.450B | 8.72 |
| AdaptHealth (AHCO) | United States | $1.412B | 10.19 |
| Verano Holdings (VRNOF) | United States | $1.196B | 0.00 |
| BioLife Solutions (BLFS) | United States | $1.111B | 0.00 |
| Evolus (EOLS) | United States | $1.057B | 0.00 |
| Owens & Minor (OMI) | United States | $1.030B | 7.95 |
| Phibro Animal Health (PAHC) | United States | $0.939B | 19.48 |
| CeriBell (CBLL) | United States | $0.899B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.883B | 0.00 |
| National Vision Holdings (EYE) | United States | $0.866B | 27.52 |
| Cresco Labs (CRLBF) | United States | $0.740B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.540B | 16.30 |
| Surmodics (SRDX) | United States | $0.537B | 114.03 |
| Quanterix (QTRX) | United States | $0.515B | 0.00 |
| Valneva SE (VALN) | France | $0.467B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.456B | 0.00 |
| ZimVie (ZIMV) | United States | $0.387B | 32.65 |
| Viemed Healthcare (VMD) | United States | $0.334B | 35.88 |
| Jin Medical (ZJYL) | China | $0.318B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.311B | 8.02 |
| TerrAscend (TSNDF) | Canada | $0.309B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.304B | 0.00 |
| Sanara MedTech (SMTI) | United States | $0.293B | 0.00 |
| Biote (BTMD) | United States | $0.284B | 13.07 |
| Cerus (CERS) | United States | $0.282B | 0.00 |
| Zynex (ZYXI) | United States | $0.279B | 58.40 |
| Ayr Wellness (AYRWF) | United States | $0.267B | 0.00 |
| MacroGenics (MGNX) | United States | $0.243B | 0.00 |
| Omeros (OMER) | United States | $0.236B | 0.00 |
| High Tide (HITI) | Canada | $0.230B | 95.33 |
| Utah Medical Products (UTMD) | United States | $0.223B | 15.01 |
| Organigram Holdings (OGI) | Canada | $0.188B | 0.00 |
| Brainsway (BWAY) | Israel | $0.171B | 204.60 |
| FitLife Brands (FTLF) | United States | $0.146B | 19.75 |
| Rockwell Medical (RMTI) | United States | $0.118B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.118B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.113B | 0.00 |
| Veru (VERU) | United States | $0.112B | 0.00 |
| Fonar (FONR) | United States | $0.097B | 9.97 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.095B | 23.20 |
| Jushi Holdings (JUSHF) | United States | $0.086B | 0.00 |
| Zevia PBC (ZVIA) | United States | $0.084B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.082B | 0.00 |
| InterCure (INCR) | Israel | $0.080B | 0.00 |
| Modular Medical (MODD) | United States | $0.072B | 0.00 |
| Safety Shot (SHOT) | United States | $0.063B | 0.00 |
| MariMed (MRMD) | United States | $0.061B | 0.00 |
| Sanuwave Health (SNWVD) | United States | $0.056B | 1.43 |
| Cytosorbents (CTSO) | United States | $0.054B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.046B | 0.00 |
| Exagen (XGN) | United States | $0.045B | 0.00 |
| Apyx Medical (APYX) | United States | $0.041B | 0.00 |
| ImmuCell (ICCC) | United States | $0.028B | 0.00 |
| Flora Growth (FLGC) | United States | $0.018B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.017B | 0.00 |
| Nephros (NEPH) | United States | $0.015B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.013B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.012B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.010B | 0.00 |
| NeuroMetrix (NURO) | United States | $0.008B | 0.00 |
| Agape ATP (ATPC) | $0.007B | 0.00 | |
| Sharps Technology (STSS) | United States | $0.005B | 0.00 |
| Leafly Holdings (LFLY) | United States | $0.004B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.004B | 0.00 |
| Akanda (AKAN) | United Kingdom | $0.002B | 0.00 |
| Senestech (SNES) | United States | $0.001B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.001B | 0.00 |
| United-Guardian (UG) | United States | $0.000B | 18.04 |
| SNDL (SNDL) | Canada | $0.000B | 0.00 |